Related references
Note: Only part of the references are listed.MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
Paolo A. Ascierto et al.
LANCET ONCOLOGY (2013)
Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
Alexander M. Menzies et al.
CLINICAL CANCER RESEARCH (2012)
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Arne Warth et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Clinicopathologic study of 85 cases of melanoma of the female genitalia
Win J. Tcheung et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
Gerald S. Falchook et al.
LANCET (2012)
KIT Pathway Alterations in Mucosal Melanomas of the Vulva and Other Sites
Katarina Omholt et al.
CLINICAL CANCER RESEARCH (2011)
Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring c-Kit Mutation or Amplification
Jun Guo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Esophageal melanomas harbor frequent NRAS mutations unlike melanomas of other mucosal sites
Shigeki Sekine et al.
VIRCHOWS ARCHIV (2009)
Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
I. Satzger et al.
BRITISH JOURNAL OF CANCER (2008)
Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas
S. Aulmann et al.
HISTOPATHOLOGY (2007)
Ultraviolet radiation and melanoma: A systematic review and analysis of reported sequence variants
Thomas Hocker et al.
HUMAN MUTATION (2007)
Issues affecting molecular staging in the management of patients with melanoma
G. Palmieri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Somatic activation of KIT in distinct subtypes of melanoma
John A. Curtin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
An immunohistochemical evaluation of c-kit (CD-117) expression in malignant melanoma, and results of imatinib mesylate (Gleevec) therapy in three patients
JB Alexis et al.
MELANOMA RESEARCH (2005)
The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated
R Penzel et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Population-based incidence rates of malignant melanoma of the vulva in Germany
A Stang et al.
GYNECOLOGIC ONCOLOGY (2005)
Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites
Y Cohen et al.
CLINICAL CANCER RESEARCH (2004)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Share Paper
